AtriCure Debt to Equity Ratio 2010-2025 | ATRC
Current and historical debt to equity ratio values for AtriCure (ATRC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AtriCure debt/equity for the three months ending March 31, 2025 was 0.16.
| AtriCure Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.14B | $0.46B | 0.30 |
| 2024-12-31 | $0.15B | $0.46B | 0.32 |
| 2024-09-30 | $0.15B | $0.47B | 0.32 |
| 2024-06-30 | $0.14B | $0.46B | 0.29 |
| 2024-03-31 | $0.14B | $0.46B | 0.30 |
| 2023-12-31 | $0.15B | $0.47B | 0.32 |
| 2023-09-30 | $0.14B | $0.46B | 0.30 |
| 2023-06-30 | $0.13B | $0.46B | 0.29 |
| 2023-03-31 | $0.13B | $0.46B | 0.28 |
| 2022-12-31 | $0.13B | $0.46B | 0.28 |
| 2022-09-30 | $0.13B | $0.45B | 0.29 |
| 2022-06-30 | $0.13B | $0.46B | 0.29 |
| 2022-03-31 | $0.12B | $0.46B | 0.26 |
| 2021-12-31 | $0.13B | $0.48B | 0.27 |
| 2021-09-30 | $0.13B | $0.49B | 0.26 |
| 2021-06-30 | $0.32B | $0.39B | 0.82 |
| 2021-03-31 | $0.31B | $0.39B | 0.79 |
| 2020-12-31 | $0.30B | $0.41B | 0.73 |
| 2020-09-30 | $0.29B | $0.42B | 0.70 |
| 2020-06-30 | $0.29B | $0.42B | 0.69 |
| 2020-03-31 | $0.30B | $0.23B | 1.32 |
| 2019-12-31 | $0.31B | $0.25B | 1.26 |
| 2019-09-30 | $0.30B | $0.26B | 1.17 |
| 2019-06-30 | $0.10B | $0.24B | 0.42 |
| 2019-03-31 | $0.10B | $0.24B | 0.41 |
| 2018-12-31 | $0.11B | $0.25B | 0.43 |
| 2018-09-30 | $0.11B | $0.16B | 0.66 |
| 2018-06-30 | $0.11B | $0.16B | 0.70 |
| 2018-03-31 | $0.12B | $0.15B | 0.76 |
| 2017-12-31 | $0.11B | $0.16B | 0.66 |
| 2017-09-30 | $0.11B | $0.16B | 0.69 |
| 2017-06-30 | $0.11B | $0.16B | 0.66 |
| 2017-03-31 | $0.11B | $0.16B | 0.66 |
| 2016-12-31 | $0.11B | $0.17B | 0.64 |
| 2016-09-30 | $0.11B | $0.17B | 0.61 |
| 2016-06-30 | $0.11B | $0.18B | 0.59 |
| 2016-03-31 | $0.08B | $0.18B | 0.45 |
| 2015-12-31 | $0.09B | $0.19B | 0.46 |
| 2015-09-30 | $0.04B | $0.13B | 0.32 |
| 2015-06-30 | $0.03B | $0.13B | 0.24 |
| 2015-03-31 | $0.03B | $0.13B | 0.19 |
| 2014-12-31 | $0.03B | $0.13B | 0.20 |
| 2014-09-30 | $0.02B | $0.14B | 0.16 |
| 2014-06-30 | $0.02B | $0.13B | 0.16 |
| 2014-03-31 | $0.02B | $0.13B | 0.18 |
| 2013-12-31 | $0.04B | $0.07B | 0.54 |
| 2013-09-30 | $0.02B | $0.04B | 0.59 |
| 2013-06-30 | $0.02B | $0.04B | 0.51 |
| 2013-03-31 | $0.02B | $0.04B | 0.51 |
| 2012-12-31 | $0.02B | $0.01B | 1.59 |
| 2012-09-30 | $0.02B | $0.01B | 1.49 |
| 2012-06-30 | $0.02B | $0.02B | 1.41 |
| 2012-03-31 | $0.02B | $0.02B | 1.50 |
| 2011-12-31 | $0.02B | $0.02B | 1.17 |
| 2011-09-30 | $0.02B | $0.02B | 1.12 |
| 2011-06-30 | $0.02B | $0.02B | 1.14 |
| 2011-03-31 | $0.02B | $0.02B | 1.29 |
| 2010-12-31 | $0.02B | $0.02B | 1.02 |
| 2010-09-30 | $0.02B | $0.02B | 1.27 |
| 2010-06-30 | $0.02B | $0.02B | 1.21 |
| 2010-03-31 | $0.02B | $0.02B | 1.09 |
| 2009-12-31 | $0.02B | $0.02B | 1.05 |
| 2009-09-30 | $0.02B | $0.02B | 0.97 |
| 2009-06-30 | $0.01B | $0.02B | 0.57 |
| 2009-03-31 | $0.01B | $0.02B | 0.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.692B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.094B | 27.91 |
| Boston Scientific (BSX) | United States | $148.004B | 37.05 |
| Stryker (SYK) | United States | $145.912B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $130.051B | 0.00 |
| Medtronic (MDT) | Ireland | $112.158B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.407B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.971B | 27.90 |
| ResMed (RMD) | United States | $36.801B | 27.64 |
| Agilent Technologies (A) | United States | $33.162B | 21.62 |
| GE HealthCare Technologies (GEHC) | United States | $32.817B | 15.58 |
| Terumo (TRUMY) | Japan | $26.665B | 34.63 |
| Koninklijke Philips (PHG) | Netherlands | $22.070B | 15.86 |
| Insulet (PODD) | United States | $21.511B | 84.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.366B | 11.80 |
| Baxter (BAX) | United States | $15.831B | 11.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.086B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.138B | 21.36 |
| Lantheus Holdings (LNTH) | United States | $5.758B | 14.52 |
| Prestige Consumer Healthcare (PBH) | United States | $4.234B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.598B | 9.12 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.442B | 15.68 |
| ICU Medical (ICUI) | United States | $3.353B | 24.73 |
| Envista Holdings (NVST) | United States | $3.224B | 26.79 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.043B | 14.05 |
| LeMaitre Vascular (LMAT) | United States | $1.883B | 42.08 |
| Acuren (TIC) | United States | $1.348B | 0.00 |
| Neogen (NEOG) | United States | $1.198B | 15.33 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.132B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.087B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.082B | 24.33 |
| Phibro Animal Health (PAHC) | United States | $0.982B | 12.55 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Capricor Therapeutics (CAPR) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.581B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.413B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.91 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.327B | 58.20 |
| Canopy Growth (CGC) | Canada | $0.298B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Cresco Labs (CRLBF) | United States | $0.263B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.89 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.05 |
| Quanterix (QTRX) | United States | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.08 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.184B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.40 |
| Vireo Growth (VREOF) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.43 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |